ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE

Clinical trials for ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE explained in plain language.

Never miss a new study

Get alerted when new ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE trials appear

Sign up with your email to follow new studies for ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 3 Completed 2

Can a smart immune cell with a kill switch beat tough lymphomas?

⭐️ CURE ⭐️ Not yet recruiting

This Phase 1 trial tests a new type of cell therapy for people with relapsed or refractory CD30-positive lymphomas, including Hodgkin lymphoma and certain non-Hodgkin lymphomas. The treatment uses a patient's own immune cells that are genetically engineered to recognize and attac…

Matched conditions: ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE

Phase: PHASE1 • Sponsor: The Methodist Hospital Research Institute • Aim: ⭐️ CURE ⭐️

Last updated Jul 29, 2026 00:00 UTC

ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE

Get alerted when new ANAPLASTIC LARGE CELL LYMPHOMA, ALK-POSITIVE trials appear

Can a smart immune cell with a kill switch beat tough lymphomas?